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RING finger proteins have been implicated in many
fundamental cellular processes, including the control of
gene expression. A key regulator of light-dependent de-
velopment in Arabidopsis thaliana is the constitutive
photomorphogenesis protein 1 (atCOP1), a RING finger
protein that plays an essential role in translating light/
dark signals into specific changes in gene transcription.
atCOP1 binds the basic leucine zipper factor HY5 and
suppresses its transcriptional activity through a yet un-
defined mechanism that results in HY5 degradation in
response to darkness. Furthermore, the pleiotropic phe-
notype of atCOP1 mutants indicates that atCOP1 may be
a central regulator of several transcriptional pathways.
Here we report the cloning and characterization of the
human orthologue of atCOP1. Human COP1 (huCOP1)
distributes both to the cytoplasm and the nucleus of cells
and shows a striking degree of sequence conservation
with atCOP1, suggesting the possibility of a functional
conservation as well. In co-immunoprecipitation assays
huCOP1 specifically binds basic leucine zipper factors of
the Jun family. As a functional consequence of this inter-
action, expression of huCOP1 in mammalian cells down-
regulates c-Jun-dependent transcription and the expres-
sion of the AP-1 target genes, urokinase and matrix
metalloproteinase 1. The RING domain of huCOP1 dis-
plays ubiquitin ligase activity in an autoubiquitination
assay in vitro; however, suppression of AP-1-dependent
transcription by huCOP1 occurs in the absence of
changes in c-Jun protein levels, suggesting that this in-
hibitory effect is independent of c-Jun degradation. Our
findings indicate that huCOP1 is a novel regulator of
AP-1-dependent transcription sharing the important
properties of Arabidopsis COP1 in the control of gene
expression.
RING finger domains are found in a large number of proteins
involved in many fundamental cellular processes, such as pro-
liferation, apoptosis, development, oncogenesis, and viral path-
ogenicity (1–3). The RING domain is characterized by a con-
served pattern of cysteine and histidine residues that bind two
zinc atoms in a particular cross-brace arrangement. A unifying
function for the RING has been difficult to define, given the
large number of molecular pathways that are affected by RING
proteins. It has been proposed that a general feature of RING
domains is the ability to mediate interactions with other
RING or non-RING proteins and to contribute to the assembly
of macromolecular complexes (1). More recently, a role for
RING domains in ubiquitination reactions has been identified,
and several RING finger proteins have demonstrated ubiquitin
ligase activity, with the ability to transfer ubiquitin to a sub-
strate as well as to themselves (4–6).
Many RING finger proteins have been implicated in regulat-
ing transcription through a variety of mechanisms (7), includ-
ing ubiquitination and degradation of positive (8–12) or nega-
tive regulators of transcription (13–15). Pathways independent
of protein degradation have also been described and may in-
volve protein sumoylation (16), changes in promoter recruit-
ment (17), interference with components of the transcriptional
machinery, such as general transcription factors (18, 19) or
RNA polymerase II (20, 21), changes in histone acetylation (22,
23), or chromatin rearrangement (24, 25).
The Arabidopsis thaliana RING finger constitutive photo-
morphogenesis protein 1 (atCOP1),1 has been characterized for
the profound effect that loss of function mutations have on
Arabidopsis photomorphogenic development (26). atCOP1 in-
fluences Arabidopsis growth by regulating the pattern of gene
expression in seedlings. Work from X. W. Deng’s laboratory
(27) demonstrated that under defined extracellular conditions
(darkness) atCOP1 accumulates in the nucleus, where it binds
one or more transcriptional regulators, such as the basic
leucine zipper (bZIP) factor HY5 (28). Degradation of HY5 in
the dark is dependent on the presence of wild type at COP1 in
the nucleus (29). In addition, COP1 seems to interact function-
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ally with other proteins, because nuclear accumulation of at-
COP1 requires the activity of several genes (26), many of which
encode subunits of a single multimolecular complex, the COP9
signalosome (CSN) (30).
Our laboratory has been investigating the role of the mam-
malian CSN and its functional regulation in response to extra-
cellular signals, such as intercellular adhesion (31). Because
atCOP1 is integral to the function of the plant CSN, we sought
to obtain further insight into the function of the mammalian
CSN by studying the human COP1 orthologue. In this paper we
report the cloning and characterization of human COP1 (hu-
COP1). Similar to its plant counterpart, huCOP1 contains
seven WD40 repeats in the carboxyl terminus and an amino-
terminal RING domain, which displays ubiquitin ligase activ-
ity in an autoubiquitination assay in vitro. We show that hu-
COP1 possesses a nuclear localization sequence (NLS) that
directs distribution of the protein to the nucleus. In co-immu-
noprecipitation assays huCOP1 specifically binds transcription
factors of the Jun family through a highly conserved amino acid
motif. The functional consequence of this interaction is the
down-regulation of c-Jun transcriptional activity by ectopically
expressed huCOP1 protein. Our findings indicate that also in
human cells COP1 may function as a regulator of gene expres-
sion, affecting the AP-1-dependent pathway, which plays
a central role in mammalian cell proliferation and
differentiation.
EXPERIMENTAL PROCEDURES
Cloning of huCOP1—Translated BLAST search of a human ex-
pressed sequence tag data bank revealed several expressed sequence
tags with a high degree of identity with A. thaliana COP1. IMAGE clone
1707833 was obtained from Human Genome Mapping Project Resource
Center (Cambridge, UK) and used to screen a phage library from
NT2/D1 cells (Stratagene). A positive clone was amplified, and phage
DNA was extracted. The cDNA insert (2.6 kb) was excised and se-
quenced. Primer extension experiments and 5 rapid amplification of
cDNA ends-PCR revealed that although huCOP1 cDNA extended fur-
ther 5 for 500 nucleotides, an in-frame stop codon was present 150
nucleotides upstream of the identified ATG (GenBankTM accession
number: NP_071902). HeLa cell RNA was extracted with the RNAeasy
kit (Qiagen) following the manufacturer’s instructions. For primer ex-
tension assays, 50 g of total RNA were precipitated overnight with 40
pmol of each of the following 32P-labeled primers: COP1.16, 5-GGCT-
ACCAGACATCGTGACTCC-3, and COP1.17, 5-GGATAAAGACGAG-
GAGGCGGAAGTCACCGA-3. Annealing occurred in hybridization
buffer (150 mM KCl, 10 mM Tris, pH 7.5, 1 mM EDTA) at progressively
decreasing temperatures (from 80 to 42 °C), retrotranscription was
carried out with the Superscript II enzyme (Invitrogen) at 42 °C. After
RNase treatment and phenol/chloroform extraction, the samples were
precipitated and resolved on a 6% polyacrylamide sequencing gel. Am-
plification of 5 cDNA ends was performed with the above primers and
the GeneRacer kit (Invitrogen), following the manufacturer’s protocol.
Sequence homologies were determined with the ClustalW multiple
alignment tool.
Northern Blot Analysis—huCOP1 cDNA was digested with EcoRI to
yield a 900-nucleotide fragment. After gel purification, the probe was
labeled with [32P]dCTP using a Rediprime II kit (Amersham Bio-
sciences) and hybridized to commercial Northern blot membranes
(FirstChoice Northern Human Blot 1 and FirstChoice Northern Human
Blot 2; Ambion) containing 2 g of poly(A) RNA from different human
tissues. The membranes were stripped and subsequently probed with a
-actin cDNA probe.
Production of Monoclonal Antibodies and Western Blotting—The
amino-terminal fragment of COP1 (amino acids 1–452) was cloned into
pGEX4T1 (Pharmacia Corp.). Recombinant GST-COP1 was purified
from Escherichia coli by binding to glutathione-Sepharose (Pharmacia
Corp.) and used to raise monoclonal antibodies against COP1 (SP212).
SP212 recognized overexpressed FLAG-COP1 by Western blotting and
by indirect immunofluorescence. Lysates from transfected COS-7 cells
and human cell lines were obtained by boiling samples for 5 min in 2%
SDS, followed by the addition of RIPA correction buffer (32). Tissue
homogenates from rat embryo (embryonic day 18.5) brains were ob-
tained by mechanical lysis in hypotonic buffer (20 mM HEPES, pH 7.4,
1 mM EDTA, 1 mM Pefabloc SC; Roche Applied Science), cleared by
centrifugation (13,000 rpm, 30 min) and filtration (0.3 micron), and
analyzed by denaturing SDS-PAGE and Western blotting with SP212
or antibodies against -tubulin (Sigma). Detection was performed with
the ECL Plus reagent (Amersham Biosciences).
Indirect Immunofluorescence—Full-length COP1 or PCR amplifica-
tions of the indicated truncation products of COP1 (RINGcc, 1–344;
RING, 1–214; ccWD40, 208–731; and WD40, 401–731) were cloned into
the pFLAG-CMV2 vector. Mutations in the NLS of full-length COP1
and of RINGcc were introduced by site-directed mutagenesis using the
PCR-based method QuikChange (Stratagene). Arg111 and Arg113 were
both mutated to alanine. COS7 cells were grown on glass coverslips in
35-mm dishes and transfected using the FuGENE 6 reagent (Roche
Applied Science). 0.2 g of DNA/35-mm dish were used. 48 h after
transfection, the cells were fixed with 4% paraformaldehyde, permeabil-
ized with 0.1% Nonidet P-40, and incubated with anti-FLAG antibodies
(M5; Sigma), followed by fluorescein isothiocyanate anti-mouse anti-
serum. The cells were analyzed with a Bio-Rad laser scanning confocal
microscope MRC-1024.
Co-immunoprecipitations—COS7 cells in 60-mm dishes were trans-
fected using FuGENE 6 and 0.6 g of the indicated cDNAs. The lysates
were harvested after 48 h in Nonidet P-40 lysis buffer (20 mM Tris, pH
7.4, 150 mM NaCl, 1% Nonidet P-40, with protease inhibitors). Post-
nuclear supernatants were cleared by incubation with protein G-Sepha-
rose (Amersham Biosciences) for 30 min at 4 °C and then incubated
with anti-FLAG antibodies (M5) or anti-HA antibodies (12CA5) for 1 h
at 4 °C, followed by the addition of protein G-Sepharose and further
incubation for 20 min. Bound proteins were washed four times with
lysis buffer and eluted with Laemmli sample buffer. The samples were
loaded on 10% SDS-PAGE, transferred to polyvinylidene difluoride
membranes, and incubated with the indicated antibodies. Anti-c-Jun,
anti-JunD, and anti-c-Fos antibodies were from Santa Cruz Biotechnol-
ogy, Inc. Detection was performed with the ECL Plus system (Amer-
sham Biosciences).
In Vitro Ubiquitination Assay—Mutations in the RING domain of
full-length COP1 and of the RINGcc deletion mutant were introduced
by site-directed mutagenesis using the PCR-based method QuikChange
(Stratagene). Cysteine 456 and 459 were mutated to alanine. Full-
length COP1, COP1 RINGcc (amino acids 1–412), and the respective
RING mutants were subcloned into the pGEX4T1 vector (Pharmacia
Corp.), expressed in E. coli BL21 (DE3) and purified from bacterial
lysates with glutathione-Sepharose 4B beads (Amersham Biosciences).
His-tagged ubiquitin (a gift from M. Pagano), engineered to contain a
protein kinase recognition site (LRRASV), was purified with nickel
beads and labeled with 32P by incubating [-32P]ATP and cAMP kinase
(Sigma) at 37 °C for 30 min. In vitro ubiquitination assays were per-
formed as described (4). Briefly, reaction mixtures containing 0.3 g of
GST fusion proteins bound to GSH-Sepharose were incubated for 1 h at
30 °C in the presence of His-ubiquitin labeled with 32P and the purified
enzymes: E1 (10 ng, affinity), His-tagged UbcH5B (300 ng) in ubiquiti-
nation buffer (25 mM Tris, pH 7.6, 5 mM MgCl2, 0.1 M NaCl, 1 mM
dithiothreitol, 2 mM ATP). The reactions were stopped with 5 SDS
sample buffer, and the samples were resolved by SDS-PAGE. Ubiquiti-
nated proteins were detected by autoradiography.
Reporter Gene Assays—293T cells were grown in 35-mm dishes and
transfected in triplicate samples with 0.2 g of an AP-1-driven lucifer-
ase reporter gene (33), 0.1 g of a -galactosidase reporter construct, 0.2
g of RSV c-Jun, and the indicated COP1 constructs, using the Fu-
GENE 6 reagent, following the manufacturer’s protocol. After 24 h the
cells were collected, and the luciferase activity was analyzed in cell
lysates following the manufacturer’s instructions (Promega). -Galac-
tosidase activity was measured in the same samples (Roche Applied
Science). For the analysis of the urokinase promoter activity, 0.8 g of
luciferase reporter constructs containing either the Sp1 responsive
proximal promoter (86 to32) or the proximal promoter and the AP-1
enhancer region (1977/1880) in the pGLBasic vector were used (34).
Real Time Fluorogenic Reverse Transcriptase-PCR—Total RNA was
isolated from 35-mm dishes of transfected 293T or HeLa cells with the
RNeasy mini kit (Qiagen). Transfection (0.2 g of huCOP1 or empty
vector, plus 0.3 g of c-Jun, for u-PA detection or 0.3 g of c-Jun and 0.3
g of c-Fos) were conducted in triplicate. 1 g of total RNA was reverse-
transcribed with Superscript II Reverse Transcriptase, following the
manufacturer’s protocol (Invitrogen). Real time fluorogenic reverse
transcriptase-PCR was performed according to manufacturer’s instruc-
tions (PE Applied Biosystem). 10–40 ng cDNA were amplified in 25 l
of final volume in the presence of 1.25 l of the following “Assays-on-
Demand” oligonucleotides purchased from Applied Biosystems: uroki-
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nase plasminogen activator, tumor necrosis factor-, matrix metallo-
proteinase 1 (MMP1), GAPDH, and 18 S. Relative mRNA levels
(compared with mock transfected samples) were calculated according to
the manufacturer’s instructions and normalized to GAPDH mRNA
levels. Similar results were obtained with normalization to 18 S RNA
levels.
RESULTS
Cloning of Human COP1—To identify human homologues of
the atCOP1 protein, we performed a similarity search of a
human expressed sequence tag data base using a translated
Blast search program (35). An expressed sequence tag clone
whose conceptual translation showed 52% identity with at-
COP1 was chosen to screen a human cDNA library and to
isolate a 2.6-kb cDNA clone. Primer extension experiments
indicated that the mRNA start site was located 600 nucleotides
upstream of the first nucleotide of the isolated clone (not
shown). Retrotranscription of HeLa mRNA together with 5
rapid amplification of cDNA ends-PCR and sequencing of the
amplified products allowed the identification of an in-frame
STOP codon 153 bp upstream of the first ATG of the isolated
clone (see GenBankTM accession number NP_071902), confirm-
ing that it comprised the full-length coding sequence. Sequenc-
ing of the isolated clone revealed a predicted 2193-nucleotide
open reading frame, encoding a protein of 731 amino acids with
a good degree of conservation with atCOP1 (34% identity, 64%
overall similarity) (36). In particular, the analysis of huCOP1
protein domains demonstrated that all of the structural mod-
ules present in atCOP1 (26) are conserved in the human pro-
tein (Fig. 1A); in addition to seven WD40 repeats in the car-
boxyl-terminal domain (51% identity with atCOP1), preceded
by a predicted coiled-coil structure, a zinc-binding RING motif
is present in the amino-terminal portion of the protein. Two
putative NLS could be identified: a monopartite motif located
amino-terminal to the RING domain (amino acids 111–114)
and a bipartite NLS proximal to the WD40 repeats. Most of the
divergence between atCOP1 and huCOP1 is present in the
amino-terminal part, which is more extended in the human
protein.
Expression of COP1 in Mammalian Tissues—Northern blot
analysis of COP1 transcripts showed widespread expression in
normal human tissues. Highest levels were detected in testes,
placenta, skeletal muscle, and heart (Fig. 1B).
A monoclonal antibody (MoAb) raised against recombinant
huCOP1 recognized the FLAG-tagged version of the trans-
fected protein in Western blot analysis (Fig. 2A, left lane), as
well as an additional band with a slightly lower molecular
weight, compatible with the untagged endogenous protein,
present in lysates both from transfected COS7 and untrans-
fected HeLa cells (Fig. 2A). Extensive Western blot analysis of
COP1 expression in a panel of cell lines showed that endoge-
nous levels of COP1 are in general low (or undetectable) in
lysates derived from human cell lines and cultures (examples
are shown in Fig. 2 (A and B, right panel)). The anti-COP1
MoAb also recognized the murine form of the protein (Gen-
BankTM accession number NP036061; 97% identity with hu-
COP1) in lysates from embryonic rat brain and in the murine
embryonic cell lines analyzed (Fig. 2B, left panel).
Structural Determinants of the Subcellular Localization of
huCOP1—To study the role of the different protein domains in
determining huCOP1 subcellular localization, we transfected
FLAG-tagged versions of full-length huCOP1 and of various
huCOP1 deletion constructs in COS7 cells and analyzed the
distribution of the proteins by indirect immunofluorescence.
Transient expression studies demonstrated that huCOP1 is
present both in the cytoplasm and the nucleus (Fig. 2C), where
it has a speckled distribution, with preferential enrichment at
the nuclear periphery. Constructs lacking the amino-terminal
domain (FLAG-ccWD40 and FLAG-WD40; Fig. 2C, bottom row)
showed cytoplasmic localization, in contrast to mutants carry-
ing carboxyl-terminal deletions (FLAG-RINGcc and FLAG-
RING; Fig. 2C, middle rows), which are preferentially concen-
trated in the nucleus. This finding implied the existence of a
signal for nuclear localization in the amino-terminal portion of
the protein. Consistently, point mutations of Arg111 and Arg113
in the putative monopartite NLS are sufficient to prevent nu-
clear entry not only of the full-length protein but also of the
FLAG-RINGcc construct, resulting in a complete relocalization
of the protein (FLAG-COP1mNLS and FLAG-RINGccmNLS;
Fig. 2C, right panels).2
Given the role of WD40 repeats in establishing protein-pro-
tein interactions (37), it is not surprising that huCOP1 mutants
that lack these motifs showed a less localized pattern of nuclear
distribution (Fig. 2C, row 2, central panel), indicating that the
WD40 repeats may be necessary to retain huCOP1 in the
correct subnuclear location. Further deletion of the coiled-coil
region resulted in a complete diffused nuclear pattern (FLAG-
RING; Fig. 2C, row 3, central panel), suggesting that this
region may also be involved in protein-protein interactions.
In Arabidopsis, the coiled-coil domain of atCOP1 has been
implicated in the homodimerization of the protein. We tested
whether huCOP1 can also dimerize by transfecting HA-tagged
full-length huCOP1 together with either FLAG-tagged full-
length huCOP1 protein (FLAG-COP1) or one of several COP1
deletion constructs, as indicated (Fig. 3). Only constructs con-
taining the coiled-coil region of the protein (FLAG-COP1,
FLAG-RINGcc, and FLAG-ccWD40) were co-precipitated with
HA full-length huCOP1 by anti-HA antibodies, confirming the
importance of this domain for the self-dimerization of the hu-
man protein as well.
HuCOP1 Has Ubiquitin Ligase Activity in Vitro—In Arabi-
2 During revision of this paper, a report from Yi et al. (Yi, C., Wang,
H., Wei, N., and Deng, X. W. (2002) BioMed Central Cell Biology,
3(1):30, www.biomedcentral.com/1471-2121/3/30) has appeared, de-
scribing a subcellular distribution for the murine COP1, which is
strongly consistent with our findings relating human COP1.
FIG. 1. COP1 is highly conserved and it is ubiquitously ex-
pressed in human tissues. A, prediction of COP1 protein domains,
according to the Pfam data base, version 7.4. The vertical black bars
represent predicted NLS. The carboxyl-terminal half of the protein
contains seven WD40 repeats. A region between the amino-terminal
RING domain and the WD40 repeats is predicted to assume a coiled-coil
conformation. B, Northern blot analysis of huCOP1 expression in a
panel of human tissues was carried out with a cDNA probe comprising
the 5 fragment of huCOP1 (top panel). Hybridization with an actin
probe was used as a loading control (bottom panel).
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dopsis cells the presence of an intact COP1 protein is necessary
to allow proteasome-dependent degradation of the HY5 tran-
scription factor, in response to the appropriate extracellular
signals (light to darkness switch). The molecular mechanisms
through which atCOP1 acts is still unknown. It has been hy-
pothesized that atCOP1 could function as a ubiquitin ligase of
the RING family (29); however, ubiquitin ligase activity for
atCOP1 has never been demonstrated. Ubiquitination of pro-
teins requires the coordinated action of different components.
An E1 enzyme forms a high energy thioesther bond with ubiq-
uitin and transfers it to one of several E2 enzymes. E2 enzymes
transfer ubiquitin to the substrate, in concert with an E3 en-
zyme that is responsible for substrate recognition (38). Several
RING finger ubiquitin ligases have been shown to mediate
E2-dependent self-ubiquitination in vitro (4), and we used this
assay to test whether the RING domain of huCOP1 displays
ubiquitin ligase activity. A glutathione S-transferase (GST)
fusion protein with the RINGcc domains of COP1 was incu-
bated in the presence of E1, 32P-labeled ubiquitin, and UbcH5B
as a source of E2 activity. The reaction products were analyzed
by SDS-PAGE and autoradiography (Fig. 4A). Upon the addi-
tion of UbcH5B to the reaction, autoubiquitination of GST-
RINGcc was detected (Fig. 4A, right panel). No ubiquitination
was detectable when GST alone (Fig. 4B, left panel) was tested
or when a RINGcc construct carrying a mutation in the zinc-
binding residues of the RING finger was added (Fig. 4B, GST-
mutRINGcc), indicating that the RING finger of COP1 is re-
quired for the E3 activity detected in this assay. Also full-
length huCOP1 possessed ubiquitin ligase activity in this
system, although slightly weaker than the RINGcc construct
alone (not shown). As is the case for many RING finger pro-
teins, huCOP1 was also ubiquitinated in vivo (see supplemen-
tal figure).
HuCOP1 Forms Complexes with Selected bZIP Transcription
Factors—atCOP1 has been reported to directly interact with
the bZIP Arabidopsis transcription factor HY5 (28). This inter-
action is critical for atCOP1-mediated regulation of HY5 tran-
scriptional activity. We asked whether huCOP1 has the ability
FIG. 2. Mammalian COP1 is detectable in human and mammalian cells and localizes to both the nucleus and the cytoplasm. A,
anti-COP1 monoclonal antibody recognizes transfected and endogenous huCOP1. COS7 cells were transfected with 2 g of FLAG-tagged
full-length COP1 (left lane) or pCMVFLAG vector (middle lane). Total HeLa cell lysates (right lane) were extracted with 2% boiling SDS buffer.
Total cell lysates were blotted with anti-COP1 antibodies raised against recombinant COP1. B, endogenous COP1 expression was analyzed by
Western blotting with anti-COP1 antibodies of lysates from human (right panels) or murine (left panel) cell lines and tissues. Cellular content in
lysates was estimated by blotting with anti--tubulin antibodies (bottom panel). C, epitope-tagged full-length COP1 (FLAG-COP1) or the indicated
deletion constructs were transfected in COS7 cells. Distribution of the transfected proteins was analyzed by indirect immunofluorescence and
confocal microscopy. The middle panels in rows 1–3 show enlarged details of the nuclear distribution of the different constructs. Right panels, rows
1 and 2 show expression patterns of full-length COP1 and of the RINGcc truncated construct carrying a mutation (asterisk) in the first predicted
NLS. NLS mutants are exclusively localized to the cytoplasm.
FIG. 3. huCOP1 homodimerizes through its coiled-coil region.
COS7 cells were transfected with HA-tagged full-length huCOP1 and
the indicated FLAG-tagged constructs. The cell lysates were immuno-
precipitated (IP) with anti-HA MoAb (12CA5), resolved by denaturing
SDS-PAGE, and transferred to membranes. The blots were hybridized
with anti-FLAG MoAb to detect co-precipitated huCOP1 proteins (top
panel). Expression of HA-COP1 and of the deletion constructs in the
different samples was determined by blotting of whole cell lysates with
either anti-HA MoAb (middle panel) or with anti-FLAG MoAb (bottom
panel). The asterisk indicates immunoglobulin heavy chains.
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to interact with human bZIP transcription factors. We trans-
fected FLAG-COP1 together with a panel of bZIP transcription
factors and immunoprecipitated huCOP1 with anti-FLAG an-
tibodies. huCOP1 co-precipitated selectively with Jun family
members (c-Jun in Fig. 5A; JunD in Fig. 5B) but not with the
other bZIP factors tested (c-Fos, CREB1, and CREM; Fig. 5C).
JunD was also independently isolated as an interactor of hu-
COP1 (fused to the GAL4 DNA-binding domain) in a yeast
two-hybrid screen of a human B cell library (not shown).
Co-immunoprecipitation experiments of c-Jun with the dif-
ferent deletion constructs of COP1 showed that the main site of
interaction between COP1 and c-Jun lies in the WD40 domain,
as reported for the binding of HY5 to atCOP1 (39), although an
additional binding site is present in the coiled-coil region of the
protein (Fig. 5D).
Although in Arabidopsis dimerization of atCOP1 has been
reported to be necessary for the interaction with the HY5
transcription factor, in mammalian cells COP1 seems not to
require dimerization to interact with c-Jun, as shown by the
ability of the isolated WD40 domain to co-precipitate c-Jun
(Fig. 4D) in the absence of homodimerization (Fig. 3).
A consensus motif whose integrity is essential for the interac-
tion with atCOP1 has been identified in Arabidopsis proteins
that bind to atCOP1, such as HY5 or STH (40). We found that
FIG. 5. huCOP1 interacts with AP-1 transcription factors. A, c-Jun co-precipitates with huCOP1. COS7 cells were transfected with
FLAG-COP1 and c-Jun (lane 1), FLAG-COP1 alone (lane 2) or c-Jun alone (lane 3). Anti-FLAG immunoprecipitates (IP) and total cell lysates
(bottom panel) were analyzed by Western blotting with anti-FLAG or anti-c-Jun antibodies as indicated. The asterisk indicates immunoglobulin
heavy chains. B, JunD co-precipitates with huCOP1. The cells were transfected with JunD alone (lanes 1 and 3) or with JunD and FLAG-COP1
(lanes 2 and 4). Anti-FLAG immunoprecipitates (lanes 1 and 2) as well as total lysates (lanes 3 and 4) were analyzed by Western blotting with
anti-FLAG or anti-JunD antibodies. C, huCOP1 does not co-precipitate with unrelated basic zipper transcription factors. The cells were transfected
with the indicated transcription factors (c-Fos, Myc-tagged CREB1, or Myc-tagged CREM) in the absence (lanes 1 and 3) or the presence (lanes
2 and 4) of FLAG-COP1. Anti-FLAG immunoprecipitates (lanes 1 and 2) and total cell lysates (lanes 3 and 4) were analyzed by Western blotting
with anti-FLAG, anti-c-Fos, or anti-Myc tag antibodies (to detect CREB1 and CREM). The asterisks indicate immunoglobulin heavy chains in
immunoprecipitates. D, huCOP1 WD40 repeats are sufficient for the interaction with c-Jun. Full-length huCOP1 (FLAG-COP1) or the indicated
deletion mutants were immunoprecipitated from COS7 cells in the presence of overexpressed c-Jun. Immunoprecipitates (top and middle panels)
were analyzed by Western blotting with anti-c-Jun or anti-FLAG antibodies. c-Jun content in total cell lysates is shown in the bottom panel. The
asterisks indicate immunoglobulin heavy chains in immunoprecipitates.
FIG. 4. The RING domain of COP1 has ubiquitin-ligase activity. A, the recombinant amino-terminal fragment of COP1 (RING and
coiled-coil domains, GST-RINGcc) was tested in vitro for its ability to induce autoubiquitination in the presence of E1, E2, and 32P-labeled
ubiquitin. The reactions were analyzed by SDS-PAGE and autoradiography (right panel). Protein loading was controlled by Coomassie staining of
the same gel (left panel; asterisk indicates GST-RINGcc recombinant protein). In the presence of the ubiquitin-conjugating enzyme UbcH5B (first
and third lanes) discrete bands of mono- and di-ubiquitination (square bracket), as well as a high molecular weight smear of polyubiquitinated
forms were detected in the sample containing both COP1 and the E2 UbcH5B. B, mutation of cysteine residues in the RING domain of COP1
abolished the ubiquitination activity of the recombinant protein (GST-mutRINGcc) in vitro. The experiments were performed as in A. Autoradio-
grams of the reactions resolved by SDS-PAGE are shown. Recombinant GST alone shows no activity (left panel), as well as the mutant COP1
construct (right panel, third lane), even in the presence of the E2 UbcH5B. The asterisk labels ubiquitin-charged UbcH5B.
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this motif is also highly conserved in Jun family proteins (Fig.
6A). To test the relevance of this motif for the interaction between
c-Jun and huCOP1, we mutated to Ala two residues central to the
motif (Val232-Pro233), resulting in the c-JunVPAA construct (Fig.
6A). This substitution was sufficient to completely abolish bind-
ing of c-Jun to COP1 (Fig. 6B), although it did not alter the
subcellular distribution of the protein (Fig. 6B). In addition,
c-JunVPAA remained transcriptionally active (Fig. 7A).
HuCOP1 Modulates AP-1-driven Transcription—To test the
functional consequences of the observed interaction between
c-Jun and huCOP1, we transfected 293T cells with a luciferase
reporter gene under the control of an AP-1 promoter, together
with c-Jun and increasing quantities of huCOP1. c-Jun-medi-
ated transactivation was suppressed in a dose-dependent man-
ner by the presence of wild type huCOP1 (Fig. 7A, hatched bars
versus white bar). The inhibitory effect of huCOP1 depended on
the interaction with c-Jun, as demonstrated by the inability of
huCOP1 to interfere with the transcriptional activity of c-
JunVPAA (Fig. 7A, bars on the right) and by the absence of a
suppressive effect when the RINGcc deletion mutant of COP1,
lacking the main c-Jun binding site, was transfected (Fig. 7A).
Interestingly, the inhibitory effect required the presence of an
intact COP1 RING domain, although the RING domain is not
involved in binding of COP1 to c-Jun. The RING mutant of
COP1, which carries two Cys to Ala substitutions in the RING
domain, did not affect c-Jun transactivation activity (Fig. 7A,
black bars), although it still bound c-Jun in a co-immunopre-
cipitation assay (Fig. 7B), indicating that the inhibitory action
of huCOP1 on c-Jun transcriptional activity is not due to a
simple steric hindrance effect. To test whether huCOP1 could
also affect c-Jun-dependent transactivation of a natural AP-1
promoter, we transfected 293T cells with a luciferase reporter
gene comprising the basal proximal promoter and the AP-1
enhancer region of the urokinase (u-PA) gene (34) (Fig. 8A,
right bars). Transfection of huCOP1 (hatched bars) reduced
c-Jun-dependent transactivation of the AP-1 enhancer but had
no effect on the activity of the basal proximal u-PA promoter,
which is regulated by Sp family proteins (Fig. 8A, left bars)
(34). The ability of huCOP1 to modulate c-Jun activity in a
physiological promoter context was further tested by the effect
of huCOP1 expression on the mRNA levels of known AP-1
target genes, such as u-PA itself and MMP1 (41–43). These
FIG. 6. The interaction of huCOP1 with c-Jun is mediated by a
conserved motif. A, a conserved interaction motif has been identified
in A. thaliana proteins (HY5 and STH) that interact with Arabidopsis
COP1, indicated as Consensus. A similar motif is present in Jun family
transcription factors.  is any hydrophobic amino acid. B, mutation of
the consensus motif disrupts the interaction between huCOP1 and
c-Jun. COS7 cells were transfected with full-length COP1 and either
wild type c-Jun or c-JunVPAA, as indicated. Anti-FLAG immunopre-
cipitates (IP, two top panels) and total cell lysates were analyzed by
Western blotting with anti-FLAG or anti-c-Jun antibodies. The c-Jun-
VPAA protein carrying a mutation in the conserved interaction motif
conserves the same nuclear localization of wild type c-Jun in COS7
cells, as demonstrated by indirect immunofluorescent analysis of wild
type c-Jun (bottom left panel) and the VPAA c-Jun mutant (bottom right
panel) expressed in COS7 cells.
FIG. 7. huCOP1 interacts functionally with c-Jun to regulate
its transcriptional activity. A, 293T cells were transfected with an
AP-1 luciferase reporter construct, a -galactosidase reporter construct,
in the presence of either wild type c-Jun (left bars) or mutant c-Jun
VPAA (right bars). In addition, the samples were transfected with
empty vector () or the indicated microgram amounts of wild type
huCOP1 (hatched bars) or huCOP1 with a RING mutation (mutCOP1,
black bars). The total amount of DNA was kept constant with vector
DNA. RINGcc (dark gray bar); the deletion mutant of huCOP1 missing
the WD40 domain was expressed. Luciferase activity was normalized to
-galactosidase activity in each sample. The bars represent the means
and standard deviations from three (RINGcc) or nine independent
transfections, relative to the control sample (empty vector). B, huCOP1
RING mutant interacts with c-Jun. 293T cells were transfected with
c-Jun and either wild type huCOP1 (FLAG COP1) or huCOP1 with a
mutation in the RING domain (FLAG mutCOP1) or with empty vector.
Anti-FLAG immunoprecipitates (IP) were blotted for c-Jun (middle
panel). The bottom panel shows c-Jun content in total lysates. Asterisk,
antibody heavy chain. WB, Western blot.
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genes were chosen among the characterized c-Jun targets for
their c-Jun-dependent inducibility in the cellular systems used
in this study (293T or HeLa cells). The cells were transfected in
triplicate with c-Jun or c-Jun plus c-Fos to induce AP-1-de-
pendent expression of u-PA or MMP1, respectively. The sam-
ples were also transfected with either 0.2 g of huCOP1, 0.2 g
of the RING mutant of COP1, or empty vector. After 48 h, total
RNA was extracted from each sample, and the relative mRNA
levels for u-PA and MMP1 were estimated by quantitative real
time reverse transcriptase-PCR. Overexpression of huCOP1
resulted in decreased inducibility of the analyzed AP-1 target
genes (Fig. 8B, hatched bars) but did not alter the levels of the
control gene (Fig. 8B, GAPDH). Conversely, expression of mu-
tant COP1 was ineffective in regulating AP-1-dependent ex-
pression of the target genes (Fig. 8B, black bars).
HuCOP1 Does Not Directly Affect c-Jun Ubiquitination—
Because the integrity of the RING domain is necessary not only
for huCOP1 inhibitory activity on AP-1-dependent transcrip-
tion but also for huCOP1 ubiquitin ligase activity, we tested the
hypothesis that c-Jun function may be down-regulated follow-
ing ubiquitination of c-Jun by huCOP1. In an in vitro assay, the
addition of purified E1, UbcH5B, and huCOP1 alone was not
sufficient to induce ubiquitination of recombinant, bacterially
expressed c-Jun (not shown). In addition, overexpression of
huCOP1 in 293T cells did not consistently affect c-Jun steady
state levels in cell lysates, nor its half-life, as measured by
pulse-chase experiments (not shown), indicating that the tran-
scriptional inhibition activity of huCOP1 may be independent
of its ubiquitin ligase properties.
DISCUSSION
In this paper we report the cloning and characterization of
the human orthologue of the Arabidopsis RING protein at-
COP1, which plays a fundamental role in the control of gene
expression during plant development (26) by relaying light/
dark-derived signals to the transcriptional machinery. Human
COP1 shows a high degree of sequence conservation and do-
main organization with its plant counterpart. We found that
transfected huCOP1 distributed to the cytoplasm and the nu-
cleus of cells and that nuclear localization was directed by a
NLS located in the amino-terminal region of the protein. This
dual distribution may be important for huCOP1 function, be-
cause it has been demonstrated to be essential, in Arabidopsis,
for regulating COP1 activity in response to extracellular stim-
uli. Consistently, a partial, chimeric mouse/human COP1 con-
struct responded to light/dark stimuli by changing its subcel-
lular localization pattern when introduced in Arabidopsis cells,
pointing to a close functional conservation between the mam-
malian and the plant protein (44).
The putative coiled-coil region (amino acids 203–305) and
the seven WD40 motifs (amino acids 405–731) of huCOP1
represent potential interaction domains for protein partners.
The discrete nuclear pattern of huCOP1 depended on the
presence of these domains and is compatible with distribu-
tion to specific subnuclear compartments, as has been de-
scribed for other RING proteins, such as PML (45). The
coiled-coil region was also involved in huCOP1 homodimer-
ization, a property shared by atCOP1 (39). The ability of
huCOP1 to establish several protein-protein interactions is
further suggested by our preliminary gel filtration studies
(not shown) indicating that COP1 may be present in vivo in a
high molecular weight complex. These data are consistent
with the notion that the assembly in large macromolecular
structures is a frequent characteristic of proteins containing
a RING domain (1).
The striking degree of structural conservation of huCOP1
with the Arabidopsis counterpart suggested the interesting
possibility of a functional conservation as well. Central to
Arabidopsis COP1 biological function in seedling development
is the regulation of a bZIP protein, the photomorphogenic tran-
scription factor HY5. The inhibitory activity of atCOP1 on
HY5-dependent transcription requires the direct interaction of
the two proteins through a specific binding motif (acidic resi-
dues followed by VPD/E and a hydrophobic amino acid), pres-
ent in several COP1-binding proteins (40). We identified a
similar amino acid motif in the mammalian bZIP proteins
c-Jun and JunD, members of the AP-1 family of transcription
factors. AP-1 factors convert multiple extracellular stimuli,
such as growth factors, cytokines, and cellular stress, into a
variety of transcriptional responses. AP-1 target genes have
been implicated in many diverse biological processes, including
oncogenesis, cell survival, proliferation, and differentiation (46,
47), making the AP-1 family one of the most complex systems of
transcriptional control. Protein-protein interactions play an
important role in regulating AP-1-dependent transcription and
in controlling the specificity of AP-1 transcriptional responses
(41, 48).
FIG. 8. huCOP1 regulates the expression of AP-1 target genes.
A, huCOP1 regulates transcription from a natural AP-1-driven pro-
moter. The cells were transfected with either COP1 (0.2 g, hatched
bars) or empty vector, in the presence of a luciferase reporter construct
comprising the proximal basal promoter of the urokinase gene (left
bars) or the proximal promoter and the AP-1-dependent urokinase
enhancer (right bars). The luciferase activity was normalized to -ga-
lactosidase activity in each sample. The bars represent the averages
and standard deviations from six independent transfections. B, hu-
COP1 down-regulates mRNA levels of AP-1 target genes. HeLa cells
(left and right panels) or 293T cells were transfected with c-Jun (left and
right panels) or c-Jun plus c-Fos (middle panel), in the presence of
either wild type COP1 (hatched bars) or RING mutant COP1 (black
bars). mRNA levels for urokinase (u-PA), MMP1, and GAPDH were
estimated in total RNA samples by fluorogenic real time reverse tran-
scriptase-PCR. Shown are expression levels, normalized to 18 S ampli-
fication levels in each sample and calculated relative to the expression
level of the target gene in the mock transfected sample. The bars
represent the means and standard deviations from six (u-PA and
GAPDH) or three (MMP-1) independent transfections.
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The COP1-binding motif we identified in c-Jun and JunD
mediated the interaction between these factors and huCOP1
and suggested that this highly conserved pathway is involved
in the regulation of Jun-dependent transcription. Consistently,
expression of huCOP1 inhibited in a dose-dependent fashion
c-Jun-dependent transcription both of synthetic promoter-re-
porter constructs and of known AP-1 target genes. Further,
this effect required the integrity of the COP1-binding
consensus.
The molecular basis of Arabidopsis COP1 suppressive activ-
ity on transcription are unknown; however, it has been hypoth-
esized that COP1 may function as a ubiquitin ligase that di-
rectly targets transcription factors for degradation, based on
the presence of the RING finger domain and on the ability of
atCOP1 to permit degradation of HY5 in response to the ade-
quate extracellular stimulus (29). We found that the integrity
of the RING domain is important for huCOP1 inhibitory activ-
ity on AP-1-dependent transcription, and this prompted us to
test a possible role of huCOP1 in inducing the degradation of
c-Jun.
Overexpression of huCOP1 in two different cellular systems
(COS7 and 293T cells) did not result in a decrease of c-Jun
steady state levels in total cell lysates, nor in a reduction of
c-Jun half-life, as analyzed by pulse-chase experiments (not
shown). Consistently, in our in vitro ubiquitination assay we
could demonstrate that the RING of huCOP1 has indeed ubiq-
uitinating activity toward COP1 itself, but it is not capable of
inducing ubiquitination of a recombinant c-Jun protein, in the
presence of purified E1 and UbcH5B (not shown). Our findings
raise the possibility that ubiquitination of c-Jun by huCOP1
may occur only in the presence of another yet to be identified
component of the ubiquitin ligase complex requiring the integ-
rity of huCOP1 RING finger domain for its function. This
hypothesis is supported by the recent findings by Hardtke et al.
(49) that the Arabidopsis COP1-interacting protein CIP8 pro-
motes ubiquitination of HY5 in vitro, suggesting that ubiquiti-
nation of HY5 in vivo could require the formation of a multi-
molecular complex that includes both COP1 and CIP8.
Alternatively, we cannot rule out the possibility that signal-
dependent post-translational modifications of c-Jun may be
necessary to render the molecule susceptible to ubiquitination
or to proteasome-dependent proteolysis. Furthermore, a spe-
cific (and still unknown) extracellular cue could be required to
trigger COP1-dependent degradation of c-Jun in mammalian
cells, in analogy to the dark/light signals that regulate atCOP1
function in A. thaliana.
On the other hand, our observation that huCOP1 interferes
with c-Jun transcriptional activity in the presence of constant
levels of total c-Jun protein indicates that inhibition of AP-1-
dependent transcription occurs independently of protein deg-
radation, as reported for other RING finger proteins implicated
in transcriptional regulation (see Refs. 1 and 7 for reviews).
The requirement for an intact RING domain, in this case, may
reflect the importance of protein-protein interactions estab-
lished by the RING in mediating transcriptional repression
rather than its role in protein ubiquitination.
The identification of huCOP1-interacting proteins will be
of great importance to fully understand the function of hu-
COP1 in regulating c-Jun transcriptional activity. A genetic
and functional interaction between COP1 and the CSN has
been described in Arabidopsis, where loss of function mu-
tants of the CSN show morphogenic alterations virtually
indistinguishable from those of COP1 loss of function mu-
tants (50). The CSN has been implicated in the correct sub-
cellular localization of COP1, because atCOP1 is excluded
from the nucleus in CSN mutants (51). It will be of interest to
investigate the relationship between huCOP1 and the CSN.
In mammalian cells, the CSN has been implicated by differ-
ent laboratories (52–54) as well as by ours (31) in the modu-
lation of AP-1-dependent transcription. The molecular mech-
anisms through which the CSN affects c-Jun function are still
debated and may include post-translational modifications of
c-Jun (55). Whether a functional interaction with huCOP1
plays a role in this aspect of CSN activity is an interesting
possibility that still remains to be tested.
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